Approval of ivonescimab for 2L+ EGFRm NSCL; HARMONi-A is the only phase III study that demonstrates significant benefit across all subgroups for PFS,and is also the only study to achieve the primary e
SHENZHEN,China,Aug. 28,2024-- UTime Limited (NASDAQ:WTO) ("UTime" or the "Company")has officially announced the signing of a non-disclosure agreement (the "NDA") with Bow
The initiative provides opportunities forBabilou Family Singapore\'s early childhood educators to share best practices,equipping them with global insights.
LIMASSOL,Cyprus,Aug. 29,2024--Doo Prime successfully concluded a premier partner event held at the renowned Old Trafford Stadium on Saturday,August 10,2024. As one of the most significant gatherings
HONG KONG,Aug. 27,2024-- On August 22,AAC Technologies (02018.HK) held its 2024 interim results presentation in Hong Kong,delivering remarkably impressive performance.
INDIANAPOLIS and PARIS,Aug. 27,2024-- Stamus Networks,a global provider of high-performance network-based threat detection and response (NDR) systems,today announced it has been named a Sample Vendor
BRADENTON,Fla.,Aug. 27,2024-- BAIYU Holdings,Inc. ("BAIYU" or the "Company") (Nasdaq: BYU),a leading B2B bulk commodity e-commerce platform and supply chain service provider,today
PISCATAWAY,N.J.,Aug. 27,2024-- Legend Biotech (NASDAQ: LEGN),a subsidiary of GenScript Biotech Corporation (hereinafter referred to as "GenScript"),a global leader in life sciences research
BEIJING,Aug. 28,2024-- Jenscare Scientific Co.,Ltd. ("Jenscare" or the "Company") (HKEX: 9877),an innovative medical device company dedicated to interventional treatment for struct
Revenue Growth,Enhanced Profitability,and Milestone Reached in Hotel Network
HONG KONG,Aug. 20,2024-- H World Group Limited ("H World" or "the Group",NASDAQ: HTHT and HKEX: 1179.HK
